Percutaneous patent foramen ovale closure : outcomes with the Premere and Amplatzer devices

Bissessor, Naylin, Wong, Allison W., Hourigan, Lisa A., Jayasinghe, Rohan S., Scalia, Greg S., Burstow, Darryl J., Griffiths, Lyn R., Savage, Michael, & Walters, Darren L. (2011) Percutaneous patent foramen ovale closure : outcomes with the Premere and Amplatzer devices. Cardiovascular Revascularization Medicine, 12(3), pp. 164-169.

View at publisher

Abstract

BACKGROUND: Transcatheter closure of patent foramen ovale (PFO) has rapidly evolved as the preferred management strategy for the prevention of recurrent cerebrovascular events in patients with cryptogenic stroke and presumed paradoxical embolus. There is limited outcome data in patients treated with this therapy particularly for the newer devices.

METHODS: Data from medical records, catheter, and echocardiography databases on 70 PFO procedures performed was collected prospectively.

RESULTS: The cohort consisted of 70 patients (mean age 43.6 years, range 19 to 77 years), of whom 51% were male. The indications for closure were cryptogenic cerebrovascular accident (CVA) or transient ischemic attack (TIA) in 64 (91%) and peripheral emboli in two (2.8%) patients and cryptogenic ST-elevation myocardial infarction in one (1.4%), refractory migraine in one (1.4%), decompression sickness in one (1.4%), and orthodeoxia in one (1.4%) patient, respectively. All patients had demonstrated right-to-left shunting on bubble study. The procedures were guided by intracardiac echocardiography in 53%, transesophageal echocardiography in 39%, and the remainder by transthoracic echo alone. Devices used were the Amplatzer PFO Occluder (AGA Medical) (sizes 18-35 mm) in 49 (70%) and the Premere device (St. Jude Medical) in 21 (30%). In-hospital complications consisted of one significant groin hematoma with skin infection. Echocardiographic follow-up at 6 months revealed that most patients had no or trivial residual shunt (98.6%), while one patient (1.4%) had a mild residual shunt. At a median of 11 months' follow-up (range 1 month to 4.3 years), no patients (0%) experienced further CVA/TIAs or paradoxical embolic events during follow-up.

CONCLUSION: PFO causing presumed paradoxical embolism can be closed percutaneously with a low rate of significant residual shunting and very few complications. Recurrent index events are uncommon at medium-term (up to 4 years) follow-up.

Impact and interest:

9 citations in Scopus
Search Google Scholar™

Citation counts are sourced monthly from Scopus and Web of Science® citation databases.

These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.

Citations counts from the Google Scholar™ indexing service can be viewed at the linked Google Scholar™ search.

ID Code: 62571
Item Type: Journal Article
Refereed: Yes
DOI: 10.1016/j.carrev.2010.06.001
ISSN: 15538389
Divisions: Current > Institutes > Institute of Health and Biomedical Innovation
Copyright Owner: Copyright 2011 Elsevier Inc.
Deposited On: 17 Sep 2013 02:00
Last Modified: 31 Oct 2013 00:36

Export: EndNote | Dublin Core | BibTeX

Repository Staff Only: item control page